As a not-for-profit organization, Lygature aims to accelerate the development of new medical solutions for patients by driving public-private collaboration between academia, industry and society.As program manager, I'm currently involved in the following Consortia:- https://www.pediatricpraziquantelconsortium.org/- https://amr-accelerator.eu/project/gna-now/- https://www.unite4tb.org/

Project: Immune modulation by helminths and the impact on the development of type 2 diabetes.The main objective of this project is to improve the understanding of the role of helminth infections in the development of insulin resistance, hence type 2 diabetes, and to gain insight into the immunological mechanisms underlying this possible association. To this end, a large-scale clinical trial was conducted in a rural area of Indonesia on Flores Island, in collaboration with the Faculty of Medicine, Universitas Indonesia (FKUI) in Jakarta, Indonesia. (www.sugarspin.org)Successfully defended my thesis on 26 March, 2019.

Project: Targeted delivery of IFNγ to activated hepatic stellate cells in liver fibrosis

Project title: Incubation of rat intestinal slices in a microfluidic device.

Project title: Development of targeted SAINT-O-Somes as a versatile lipid based drug delivery system for treatment of inflammatory diseases and cancer.